I. Souglakos

发表

Projecting Event-Based Analysis Dates in Clinical Trials: An Illustration Based on the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) Collaboration. Projecting Analysis Dates for the IDEA Collaboration

D. Sargent, T. Yamanaka, I. Floriani, 2014, Forum of clinical oncology.

Artificial intelligence radiogenomics for advancing precision and effectiveness in oncologic care (Review)

A. Karantanas, D. Spandidos, A. Tsatsakis, 2020, International journal of oncology.

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.

R. Labianca, D. Kerr, I. Nagtegaal, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin

R. Labianca, J. Meyerhardt, E. Oki, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?

R. Labianca, J. Meyerhardt, M. Buyse, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

LBA21_PRProspective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): Updated results of IDEA (International Duration Evaluation of Adjuvant chemotherapy)

R. Labianca, J. Meyerhardt, D. Sargent, 2017 .

Brain and bone marrow metastases from rectal cancer

M. Tzardi, D. Mavroudis, G. Kanellis, 2019, Annals of gastroenterology.

Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer

R. Labianca, E. Oki, T. Yamanaka, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of non-small-cell lung cancer with prolonged oral etoposide.

S. Agelaki, V. Georgoulias, G. Chalkiadakis, 1998, American journal of clinical oncology.

A feasibility study of circulating melanoma cells in the perioperative context of hyperthermic isolated limb perfusion (HILP) in 20 patients

C. Ioannou, K. Lasithiotakis, O. Zoras, 2021, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials.

R. Labianca, J. Meyerhardt, V. Torri, 2020, The Lancet. Oncology.

Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project

C. Tournigand, D. Sargent, R. Simes, 2018, Journal of the National Cancer Institute.

Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials

R. Labianca, J. Meyerhardt, E. Oki, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A new prognostic and predictive tool for shared decision making in stage III colon cancer.

A. Shields, P. Bruzzi, A. Grothey, 2020, European journal of cancer.

A Case Presentation of a Patient with Microsatellite Instability and BRAF Mutant Metastatic Colon Cancer and Bibliography Update

M. Tzardi, D. Mavroudis, I. Souglakos, 2019, Case reports in oncological medicine.

Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative.

R. Labianca, J. Meyerhardt, M. Shah, 2020, European journal of cancer.

A neural pathomics framework for classifying colorectal cancer histopathology images based on wavelet multi-scale texture analysis

Georgios S. Ioannidis, M. Tzardi, A. Karantanas, 2021, Scientific Reports.

AMALTHEA: Prospective, Single‐Arm Study of the Hellenic Cooperative Oncology Group (HeCOG) Evaluating Efficacy and Safety of First‐Line FOLFIRI + Aflibercept for 6 Months Followed by Aflibercept Maintenance in Patients With Metastatic Colorectal Cancer

G. Aravantinos, C. Petraki, G. Fountzilas, 2018, Clinical colorectal cancer.

The outcome-based iCAN! / theyCAN! feedback paradigm differentiates strong and weak learning outcomes, learner diversity, and the learning outcomes of each learner: A shift to metacognitive assessment

I. Zerdes, I. Dimoliatis, E. Briasoulis, 2018, Forum of Clinical Oncology.

Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials

S. Lonardi, A. Sobrero, I. Souglakos, 2024, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.